2026-10-25
Forrester Research clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
NAS100 26,906 −5.38%
S&P 7,400 −3.75%
GOLD $4,127 +1.33%
BTC $76,159 −5.28%
VIX 24.13 +45.27%
latest tape · as of 20:03 UTC
The Screen · Industrials · Consulting Services
Forrester Research Inc
FORR · NASDAQ · USD · Market cap $238M · 1,395 employees
Forrester Research, Inc.
Not yet scored9.36 USD
Price as of 4 Nov 2026Daily close, not a live quote
Screened 2026-11-04 · the tape above runs as of 20:03 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price9.36 USD at the 4 Nov 2026 close
- Fair value10.07. Our model only; only one analyst covers it, too few to cross-check it.
- Our value readFair vs our fair value, as of 4 Nov 2026
- Our regime readDistribution, as of 5 Nov 2026
- Ethical screenNot yet scored
- Last reviewed4 Nov 2026 (1 days ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
PRICE · ONE YEAR
Our fair-value range: $10.07 to $11.77, base estimate $10.07 (screen dated 2026-11-04).
- Trend Distribution
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options no verdict drawn today, left as found
- Ethical screen not yet scored
Price9.36 USD
Fair value10.07Our model only; only one analyst covers it, too few to cross-check it.
Ethical score70.0/100
Value readFairas of 4 Nov 2026
Our investment reviews on this name
2026-10-30Read Markup12.48-25.0% to today Accumulation gives way to Markup first Markup read since October
2026-10-23Read Accumulation11.94-21.6% to today Markup gives way to Accumulation
2026-10-16Read Markup11.94-21.6% to today Markdown gives way to Markup after a 5% rise in 2 weeks
2026-10-02Read Markdown11.34-17.5% to today ✓Markup gives way to Markdown after a 62% rise in 13 weeks
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
The full research record, in depth, below
This name holds its distribution label.
Forrester Research Inc holds its Distribution at $9.36. Elevated stress, defensive posture warranted, held for 1 days.
| Phase | Distribution · caution |
| Quantitative state | Elevated stress, defensive posture warranted, held for 1 days |
| Price at the screen | $9.36 |
| Valuation | N/A trailing · 13.79 forward price to earnings |
| Values screen | Not scored · score 70.0 |
| Beta | 1.00 |
Five Screens, Shown in Full
This security has not been fully scored against the values screen yet.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 17.79% | Below 33% | Interest-bearing debt is just 17.8% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 15.92% | Below 33% | Cash held in interest-bearing accounts and securities is 15.9% of assets, under the one-third limit. | Pass |
| Receivables | 28.26% | Below 49% | Money owed to the company is 28.3% of assets, under the 49% limit. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadThe Read, in Plain English
Forrester Research clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
Read as at 2026-11-05. It updates when the underlying figures move, and past reads are kept below.
2026-09-24
Clears
Forrester Research clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 18%, inside the ~33% line, and almost none of its income is interest, so it passes.
Earlier reads, kept as written. The ethical profile is tracked over time, not overwritten.
What the Numbers Say It Is WorthThe Fair Value Range
Our model only; only one analyst covers it, too few to cross-check it.
Our analysis reads Fair vs our fair value, as of 4 Nov 2026: it trades at roughly a 5% discount to our $10.07 fair value, none competitive moat.
How a fair value is estimated: discounted cash flow (DCF).
Fair value range in USD, drawn from the 2026-11-04 screen. The gold marker is the market price at the same screen. A 7.1% discount to the base estimate.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere our models see it going: fair-value estimate $10.07, with a range of $10.07 to $11.77, dated to the 2026-11-04 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsWhy it is worth knowing
A quality business: a none moat. It trades close to our $10.07 fair value, so the easy discount is gone; you would be paying up for the quality.
| Forward P/E | 13.8xreasonably valued |
| EPS, trailing | -2.24 |
| EPS, forward | 0.91 |
| Revenue growth | -10.2%revenue is shrinking |
| Profit margin | -11.2%currently unprofitable |
| Return on equity | -30.3%not currently earning a positive return on equity |
| FCF yield | 4.87% |
| Debt to equity | 0.53moderate, manageable leverage |
| Current ratio | 1.06adequate liquidity, worth monitoring |
| Beta | 1.00steadier than the market |
| Short interest, float | 0.14% |
| 52-week range | 4.88 - 12.75 |
| Moat | NONE |
| Market cap | $238M |
| Employees | 1,395 |
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeFORR trades on NASDAQ. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
2026-10-30
Markup · changed $12.48
+4.6% Entry 9
The framework has shifted from accumulation to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 4.6% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 47% above its long-term trend line with momentum reading bullish. Over the past year the shares are down 38%. Our forward projection puts the odds of a 10% gain over the next month near 16%. The street (1 analysts) rates it none, with a mean price target of $6.
2026-10-23
Accumulation · changed $11.94
+0.0% Entry 8
The framework has shifted from markup to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 40% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 38%. Our forward projection puts the odds of a 10% gain over the next month near 16%. The street (1 analysts) rates it none, with a mean price target of $6.
2026-10-16
Markup · changed $11.94
+5.2% Entry 7
The framework has shifted from markdown to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 5.2% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 38%. Our forward projection puts the odds of a 10% gain over the next month near 16%. The street (1 analysts) rates it none, with a mean price target of $6.
2026-10-02
Markdown · changed $11.34
-3.8% Entry 6
The framework has shifted from markup to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 3.8% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 38%. Our forward projection puts the odds of a 10% gain over the next month near 16%. The street (1 analysts) rates it none, with a mean price target of $6. Since the last review it entered the Titan Ethical 500.
2026-08-29
Markup $11.79
+14.2% Entry 5
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 14.2% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 38%. Our forward projection puts the odds of a 10% gain over the next month near 16%. The street (1 analysts) rates it none, with a mean price target of $6.
2026-07-30
Markup $10.32
+47.6% Entry 4
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 47.6% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 38%. Our forward projection puts the odds of a 10% gain over the next month near 16%. The street (1 analysts) rates it none, with a mean price target of $6.
2026-07-18
Markup $6.99
+0.0% Entry 3
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 38%. Our forward projection puts the odds of a 10% gain over the next month near 16%. The street (1 analysts) rates it none, with a mean price target of $6.
2026-07-03
Markup $6.99
+0.0% Entry 2
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.
2026-07-02
Markup $6.99
Entry 1
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Forrester’s 2027 European Predictions: Despite A Strong Desire To Regain Its Digital Sovereignty, Europe Will Selectively Reset, Not Sever, Key Technology Relationships Yahoo Finance · 30 Sep 2026
- CrowdStrike (CRWD) Lands Forrester Leadership Nod As AI Security Ties Deepen Simply Wall St. · 19 Sep 2026
- CrowdStrike (CRWD) Lands Forrester Leadership Nod As AI Security Ties Deepen Yahoo Finance · 19 Sep 2026
- The Agent Production Gap: When 171% ROI Isn’t Enough to Ship Forkast News · 6 Sep 2026
- The Agent Production Gap: When 171% ROI Isn’t Enough to Ship Yahoo Finance · 6 Sep 2026
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
EGGEnigmatig Ltd
PPHCPublic Policy Holding Company Inc
RGPResources Connection Inc
SBCSBC Medical Group Holdings Inc
ROMARoma Green Finance Ltd
RYOJrYojbaba Co Ltd
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $6.59 | +2.9% | · | $1,029 | +2.9% |
| 2 months | $5.05 | +34.3% | · | $1,343 | +34.3% |
| 3 months | $6.23 | +8.8% | · | $1,088 | +8.8% |
| 6 months | $7.22 | -6.1% | · | $939 | -6.1% |
| 1 year | $10.95 | -38.1% | · | $619 | -38.1% |
| 2 years | $16.68 | -59.4% | · | $407 | -59.4% |
| 3 years | $29.20 | -76.8% | · | $232 | -76.8% |
| 5 years | $41.00 | -83.5% | · | $165 | -83.5% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever FORR does next, these words stay.
Membership
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.